Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (251-260 of 367) with videos related to

Pageof 37
Sort By:
International Orthopaedics|July 4, 2012
Surgical treatment of the haemophilic pseudotumour: a single centre experienceJoannis Panotopoulos, Cihan Ay, Klemens Trieb, et al.
Scientific Reports|February 5, 2021
The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patientsKatarina D Kovacevic, Stefan Greisenegger, Agnes Langer, et al.
Journal of Cellular and Molecular Medicine|April 13, 2024
The plasma miRNome and venous thromboembolism in high-grade glioma: miRNA Sequencing of a nested case-control cohortFriedrich Erhart, Georg Widhalm, Barbara Kiesel, et al.
Blood Advances|January 26, 2021
Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendencyDino Mehic, Alexander Tolios, Stefanie Hofer, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2019
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTHTzu-Fei Wang, Jeffrey I Zwicker, Cihan Ay, et al.
British Journal of Haematology|February 23, 2019
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studiesDavid J Kuter, Adrian Newland, Beng H Chong, et al.
Journal of Thrombosis and Haemostasis : JTH|May 22, 2025
Impaired surface receptor expression on immature platelets in bleeding patients with abnormal light transmission aggregometryDino Mehic, Anita Pirabe, Waltraud C Schrottmaier, et al.
Thrombosis and Haemostasis|January 31, 2022
Bleeding Risk Assessment in End-Stage Kidney Disease: Validation of Existing Risk Scores and Evaluation of a Machine Learning-Based ApproachStephan Nopp, Clemens P Spielvogel, Sabine Schmaldienst, et al.
Neuro-Oncology|April 26, 2023
Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary reviewJasmin Jo, Maria Diaz, Craig Horbinski, et al.
Thrombosis Research|January 16, 2023
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertensionOliver Königsbrügge, Bernhard Scheiner, Benedikt Simbrunner, et al.
Pageof 37

Showing results (251-260 of 367) with videos related to

Sort By:
Pageof 37
International Orthopaedics|July 4, 2012
Surgical treatment of the haemophilic pseudotumour: a single centre experienceJoannis Panotopoulos, Cihan Ay, Klemens Trieb, et al.
Scientific Reports|February 5, 2021
The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patientsKatarina D Kovacevic, Stefan Greisenegger, Agnes Langer, et al.
Journal of Cellular and Molecular Medicine|April 13, 2024
The plasma miRNome and venous thromboembolism in high-grade glioma: miRNA Sequencing of a nested case-control cohortFriedrich Erhart, Georg Widhalm, Barbara Kiesel, et al.
Blood Advances|January 26, 2021
Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendencyDino Mehic, Alexander Tolios, Stefanie Hofer, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2019
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTHTzu-Fei Wang, Jeffrey I Zwicker, Cihan Ay, et al.
British Journal of Haematology|February 23, 2019
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studiesDavid J Kuter, Adrian Newland, Beng H Chong, et al.
Journal of Thrombosis and Haemostasis : JTH|May 22, 2025
Impaired surface receptor expression on immature platelets in bleeding patients with abnormal light transmission aggregometryDino Mehic, Anita Pirabe, Waltraud C Schrottmaier, et al.
Thrombosis and Haemostasis|January 31, 2022
Bleeding Risk Assessment in End-Stage Kidney Disease: Validation of Existing Risk Scores and Evaluation of a Machine Learning-Based ApproachStephan Nopp, Clemens P Spielvogel, Sabine Schmaldienst, et al.
Neuro-Oncology|April 26, 2023
Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary reviewJasmin Jo, Maria Diaz, Craig Horbinski, et al.
Thrombosis Research|January 16, 2023
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertensionOliver Königsbrügge, Bernhard Scheiner, Benedikt Simbrunner, et al.
Pageof 37